Inovio Pharmaceuticals (INO) Posts Q1 Results with Data Ahead - Maxim Group
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- Applied Digital (APLD) Tops Q1 EPS by 26c, Beats on Revenue
Inovio Pharmaceuticals, Inc. (INO) Turns Positive
May 12, 2014 2:46 PM EDTInovio Pharmaceuticals, Inc. (AMEX: INO) is moving along with broader markets. Shares are now positive on the session.
Following Q1 results, Inovio dropped as much as 13.4 percent to $1.87. The stock has been crawling back since just after 10am.
Shares are about 0.2 percent higher.
... MoreInovio Pharmaceuticals, Inc. (INO) Posts Q1 Loss of 5c/Share; Updates on Cash Position
May 12, 2014 6:12 AM EDTInovio Pharmaceuticals, Inc. (AMEX: INO) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $1.41 million.
As of March 31, 2014, cash and cash equivalents plus short-term investments were $116.8 million compared with $52.6... More



